+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pharmaceutical Contract Packaging Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 191 Pages
  • November 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889443
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pharmaceutical contract packaging is undergoing transformation as industry leaders prioritize supplier flexibility, compliance, and global supply chain resilience. Navigating complex regulatory frameworks and elevated quality demands, decision-makers are focusing on partnering with providers who offer advanced technology, transparency, and regionally attuned solutions.

Market Snapshot: Pharmaceutical Contract Packaging Market

The pharmaceutical contract packaging market is forecast to grow from USD 34.82 billion in 2024 to USD 70.49 billion by 2032, reflecting a compound annual growth rate (CAGR) of 9.21%. This momentum is shaped by several converging forces, including increased adoption of patient-centric packaging, expanded production of biologic drugs, and the transition to automated methods among contract packaging providers. Market participants are investing in sustainable procurement practices, packaging innovations, and robust supply chain strategies to meet dynamic regulatory requirements and maintain compliance across diverse regions. The combination of environmental standards, shifting regulations, and technological progress is influencing market access and operational framework design on a global scale.

Scope & Segmentation: Pharmaceutical Contract Packaging

This report offers a segmentation framework designed for procurement and supply chain leaders, presenting detailed insights into the sector’s main components and strategic imperatives:

  • Automation Level: Covers a spectrum from manual processes to cutting-edge robotics, enabling flexible batch management and operational efficiency.
  • End User: Examines requirements for organizations such as innovative biopharma companies, biosimilar manufacturers, global enterprises, regional actors, and producers of generic pharmaceuticals.
  • Material Type: Evaluates materials like glass, aluminum, specialty steel, HDPE, PET, and PVC, with an emphasis on safeguarding product safety, shelf life, and adherence to regulations for pharmaceutical use.
  • Packaging Type: Includes analysis of primary and secondary packaging—ampoules, vials, blister packs, cartons, trays, pallets, and shrink wraps—to maintain product integrity and support international distribution.
  • Dosage Form: Offers insight into packaging solutions tailored for injectables, tablets, capsules, creams, and gels, improving medicine stability and supporting patient adherence.
  • Service Type: Details contract packaging offerings such as design, prototyping, labeling, serialization, batch filling, sealing, and traceability, directly supporting supply chain risk mitigation and quality assurance.
  • Regional Coverage: Provides strategic analysis for the Americas, Europe, Middle East, Africa, and Asia-Pacific, highlighting regulatory and logistics challenges unique to each market and their implications for procurement planning.
  • Company Profiles: Benchmarks leading global providers including Catalent Pharma Solutions, PCI Pharma Services, Sharp Packaging Services, and other prominent international players relevant for partner selection and competitive landscape assessment.

Key Takeaways for Senior Leaders

  • Adoption of digital-first and automation-driven packaging models supports readiness across markets, while optimizing documentation and supplier onboarding with higher scalability.
  • Investing in automation enhances operational agility, making it feasible to rapidly adapt to new or advanced product launches under tight timelines.
  • Advanced serialization and labeling increase product traceability, strengthening defenses against counterfeit risks and easing compliance with tightened authorization standards.
  • Diversifying packaging material sources regionally helps build resilience and continuity in the face of evolving local regulatory demands.
  • Tailoring strategies to align with the unique priorities of mature and emerging markets—whether advanced traceability or expandable infrastructure—enables efficient resource allocation and compliance management.
  • Collaborating through transparent, integrated packaging partnerships fosters accountability, bolsters production safeguard measures, and sustains reliability throughout distribution chains.

Tariff Impact on Pharmaceutical Supply Chains

The recent implementation of tariffs on packaging materials in the United States, including glass, aluminum closures, and select plastics, is prompting pharmaceutical firms to revisit their sourcing and production plans. Many organizations are responding by exploring nearshoring and adjusting their manufacturing logistics to gain more control and reduce exposure to external risks. This evolving landscape, combined with international economic and regulatory shifts, is fueling vertical integration efforts and driving innovation in packaging design—vital for securing operational continuity in a rapidly changing environment.

Methodology & Data Sources

This report draws on direct input from industry executives, procurement professionals, and regulatory authorities. Exclusive industry sources and peer-reviewed methodologies have been used to validate findings, ensuring actionable insights for strategic decision-making in pharmaceutical contract packaging.

Why This Report Matters

  • Presents practical strategies for overcoming regulatory uncertainty and supply chain volatility by leveraging advanced pharmaceutical contract packaging solutions.
  • Enables procurement leaders to make informed provider selections and plan technology initiatives with region-specific, data-backed analysis.
  • Empowers organizations to proactively mitigate risk and sustain market access amidst evolving compliance and supply chain challenges.

Conclusion

This report equips senior stakeholders with guidance to support global compliance, strengthen supply chain flexibility, and optimize their position in the pharmaceutical contract packaging sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Increasing adoption of advanced serialization and traceability technologies to ensure compliance with global pharmacovigilance regulations
5.2. Growing demand for sustainable and recyclable packaging materials driven by pharmaceutical industry ESG commitments
5.3. Expansion of personalized medicine packaging services catering to small-batch biologics and orphan drug therapies
5.4. Integration of IoT sensors and real-time monitoring solutions in contract packaging lines for cold chain products
5.5. Investment in automation and robotics to optimize pharmaceutical packaging throughput and reduce operational costs
5.6. Rising emphasis on child-resistant and tamper-evident packaging for high-risk medications and opioid products
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Pharmaceutical Contract Packaging Market, by Automation Level
8.1. Automated Packaging
8.1.1. Robotic Systems
8.1.2. Semi Automated Systems
8.2. Manual Packaging
9. Pharmaceutical Contract Packaging Market, by End User
9.1. Biotech Companies
9.1.1. Biopharma Innovators
9.1.2. Biosimilars Manufacturers
9.2. Brand Owners
9.2.1. Multinational Companies
9.2.2. Regional Companies
9.3. Generic Companies
9.3.1. Local Generics
10. Pharmaceutical Contract Packaging Market, by Material Type
10.1. Glass
10.1.1. Type I Glass
10.1.2. Type II Glass
10.1.3. Type III Glass
10.2. Metal
10.2.1. Aluminum
10.2.2. Steel
10.3. Plastic
10.3.1. High Density Polyethylene
10.3.2. Polyethylene Terephthalate
10.3.3. Polyvinyl Chloride
11. Pharmaceutical Contract Packaging Market, by Packaging Type
11.1. Primary
11.1.1. Ampoules
11.1.2. Blister Packs
11.1.3. Vials
11.2. Secondary
11.2.1. Cartons
11.2.2. Trays
11.3. Tertiary
11.3.1. Pallets
11.3.2. Shrink Wrap
12. Pharmaceutical Contract Packaging Market, by Dosage Form
12.1. Liquid Dosage
12.1.1. Injectable
12.1.2. Oral Solutions
12.2. Semi Solid
12.2.1. Creams
12.2.2. Gels
12.2.3. Ointments
12.3. Solid Dosage
12.3.1. Capsules
12.3.2. Tablets
13. Pharmaceutical Contract Packaging Market, by Service Type
13.1. Design & Development
13.1.1. Concept Design
13.1.2. Prototyping
13.2. Filling & Sealing
13.2.1. Liquid Filling
13.2.2. Powder Filling
13.3. Labeling
13.3.1. Pressure Sensitive
13.3.2. Wet Glue
13.4. Serialization & Track & Trace
13.4.1. Barcoding
13.4.2. RFID Tagging
14. Pharmaceutical Contract Packaging Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Pharmaceutical Contract Packaging Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Pharmaceutical Contract Packaging Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Catalent Pharma Solutions, LLC
17.3.2. PCI Pharma Services, Inc.
17.3.3. Sharp Packaging Services, Inc.
17.3.4. Aenova Holding GmbH
17.3.5. Recipharm AB
17.3.6. Almac Pharma Services Ltd
17.3.7. Vetter Pharma-Fertigung GmbH & Co. KG
17.3.8. CordenPharma International Corp.
17.3.9. Siegried Holding AG
17.3.10. Ajinomoto Bio-Pharma Services, Inc.

Companies Mentioned

The companies profiled in this Pharmaceutical Contract Packaging market report include:
  • Catalent Pharma Solutions, LLC
  • PCI Pharma Services, Inc.
  • Sharp Packaging Services, Inc.
  • Aenova Holding GmbH
  • Recipharm AB
  • Almac Pharma Services Ltd
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • CordenPharma International Corp.
  • Siegried Holding AG
  • Ajinomoto Bio-Pharma Services, Inc.

Table Information